nodes	percent_of_prediction	percent_of_DWPC	metapath
Lofexidine—ADRA2A—epilepsy syndrome	0.835	1	CbGaD
Lofexidine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00705	0.197	CbGeAlD
Lofexidine—HTR1A—ganglion—epilepsy syndrome	0.00439	0.123	CbGeAlD
Lofexidine—HTR1A—hindbrain—epilepsy syndrome	0.00333	0.0932	CbGeAlD
Lofexidine—Apraclonidine—ADRA2A—epilepsy syndrome	0.00272	0.51	CrCbGaD
Lofexidine—HTR1A—brainstem—epilepsy syndrome	0.00191	0.0534	CbGeAlD
Lofexidine—HTR1A—forebrain—epilepsy syndrome	0.00184	0.0515	CbGeAlD
Lofexidine—HTR1A—telencephalon—epilepsy syndrome	0.00169	0.0474	CbGeAlD
Lofexidine—Clonidine—ADRA2A—epilepsy syndrome	0.00136	0.255	CrCbGaD
Lofexidine—ADRA2A—forebrain—epilepsy syndrome	0.00129	0.0361	CbGeAlD
Lofexidine—HTR1A—midbrain—epilepsy syndrome	0.00122	0.034	CbGeAlD
Lofexidine—ADRA2A—telencephalon—epilepsy syndrome	0.00119	0.0332	CbGeAlD
Lofexidine—HTR1A—spinal cord—epilepsy syndrome	0.00119	0.0332	CbGeAlD
Lofexidine—HTR1A—head—epilepsy syndrome	0.00105	0.0295	CbGeAlD
Lofexidine—HTR1A—nervous system—epilepsy syndrome	0.001	0.028	CbGeAlD
Lofexidine—HTR1A—central nervous system—epilepsy syndrome	0.000962	0.0269	CbGeAlD
Lofexidine—HTR1A—cerebellum—epilepsy syndrome	0.000941	0.0263	CbGeAlD
Lofexidine—ADRA2A—medulla oblongata—epilepsy syndrome	0.000933	0.0261	CbGeAlD
Lofexidine—ADRA2A—midbrain—epilepsy syndrome	0.000852	0.0238	CbGeAlD
Lofexidine—ADRA2A—spinal cord—epilepsy syndrome	0.000832	0.0233	CbGeAlD
Lofexidine—HTR1A—brain—epilepsy syndrome	0.000764	0.0214	CbGeAlD
Lofexidine—ADRA2A—head—epilepsy syndrome	0.000739	0.0207	CbGeAlD
Lofexidine—Clonidine—CYP2D6—epilepsy syndrome	0.000731	0.137	CrCbGaD
Lofexidine—ADRA2A—nervous system—epilepsy syndrome	0.000701	0.0196	CbGeAlD
Lofexidine—ADRA2A—central nervous system—epilepsy syndrome	0.000675	0.0189	CbGeAlD
Lofexidine—ADRA2A—cerebellum—epilepsy syndrome	0.000659	0.0184	CbGeAlD
Lofexidine—ADRA2A—brain—epilepsy syndrome	0.000536	0.015	CbGeAlD
Lofexidine—Clonidine—ABCB1—epilepsy syndrome	0.000522	0.0978	CrCbGaD
Lofexidine—HTR1A—Signaling Pathways—CHRM1—epilepsy syndrome	4.9e-05	0.000395	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PDYN—epilepsy syndrome	4.9e-05	0.000395	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCR7—epilepsy syndrome	4.9e-05	0.000395	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GRM1—epilepsy syndrome	4.9e-05	0.000395	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—AGT—epilepsy syndrome	4.9e-05	0.000395	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—TXNRD1—epilepsy syndrome	4.88e-05	0.000394	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—NPY—epilepsy syndrome	4.82e-05	0.000388	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HTR7—epilepsy syndrome	4.81e-05	0.000388	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AQP1—epilepsy syndrome	4.74e-05	0.000382	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SSTR3—epilepsy syndrome	4.73e-05	0.000381	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HBEGF—epilepsy syndrome	4.67e-05	0.000377	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CRH—epilepsy syndrome	4.65e-05	0.000375	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCL3—epilepsy syndrome	4.65e-05	0.000375	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CXCL2—epilepsy syndrome	4.65e-05	0.000375	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—OXT—epilepsy syndrome	4.65e-05	0.000375	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CCR2—epilepsy syndrome	4.63e-05	0.000373	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—SST—epilepsy syndrome	4.63e-05	0.000373	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ST3GAL3—epilepsy syndrome	4.62e-05	0.000373	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	4.61e-05	0.000372	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CDC42—epilepsy syndrome	4.61e-05	0.000372	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GFAP—epilepsy syndrome	4.61e-05	0.000372	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GAL—epilepsy syndrome	4.61e-05	0.000372	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AKT3—epilepsy syndrome	4.59e-05	0.00037	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GRM5—epilepsy syndrome	4.56e-05	0.000368	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CASP2—epilepsy syndrome	4.56e-05	0.000368	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CHRM3—epilepsy syndrome	4.56e-05	0.000368	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ARHGEF9—epilepsy syndrome	4.53e-05	0.000365	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCR9—epilepsy syndrome	4.53e-05	0.000365	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SSTR1—epilepsy syndrome	4.53e-05	0.000365	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCR8—epilepsy syndrome	4.53e-05	0.000365	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NPY2R—epilepsy syndrome	4.53e-05	0.000365	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	4.49e-05	0.000363	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AVP—epilepsy syndrome	4.46e-05	0.00036	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GRM4—epilepsy syndrome	4.44e-05	0.000358	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GRM3—epilepsy syndrome	4.44e-05	0.000358	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CX3CR1—epilepsy syndrome	4.37e-05	0.000352	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—DUSP4—epilepsy syndrome	4.36e-05	0.000352	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SSTR2—epilepsy syndrome	4.36e-05	0.000352	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PLAU—epilepsy syndrome	4.35e-05	0.000351	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CXCL12—epilepsy syndrome	4.35e-05	0.000351	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—BDKRB2—epilepsy syndrome	4.35e-05	0.000351	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CHRM2—epilepsy syndrome	4.28e-05	0.000346	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CX3CL1—epilepsy syndrome	4.28e-05	0.000346	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—BDKRB1—epilepsy syndrome	4.28e-05	0.000346	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CHRM3—epilepsy syndrome	4.28e-05	0.000345	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—KCNJ11—epilepsy syndrome	4.28e-05	0.000345	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CNR1—epilepsy syndrome	4.27e-05	0.000344	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PLCB1—epilepsy syndrome	4.26e-05	0.000343	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GRM8—epilepsy syndrome	4.21e-05	0.00034	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PGF—epilepsy syndrome	4.21e-05	0.00034	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCR2—epilepsy syndrome	4.2e-05	0.000339	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—SST—epilepsy syndrome	4.2e-05	0.000339	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CDC42—epilepsy syndrome	4.19e-05	0.000338	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GABBR1—epilepsy syndrome	4.17e-05	0.000336	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—HTR7—epilepsy syndrome	4.17e-05	0.000336	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—POMC—epilepsy syndrome	4.12e-05	0.000333	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AVP—epilepsy syndrome	4.05e-05	0.000327	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PRKCB—epilepsy syndrome	4.05e-05	0.000327	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CCL2—epilepsy syndrome	4.03e-05	0.000325	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—OPRD1—epilepsy syndrome	4.02e-05	0.000324	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GNAO1—epilepsy syndrome	4.02e-05	0.000324	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—NOS2—epilepsy syndrome	4e-05	0.000323	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HRH3—epilepsy syndrome	4e-05	0.000322	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AKT3—epilepsy syndrome	3.97e-05	0.00032	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—BDKRB2—epilepsy syndrome	3.95e-05	0.000319	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CXCL12—epilepsy syndrome	3.95e-05	0.000319	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—OPRM1—epilepsy syndrome	3.93e-05	0.000317	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CNR1—epilepsy syndrome	3.88e-05	0.000313	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PLCB1—epilepsy syndrome	3.86e-05	0.000312	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GRM1—epilepsy syndrome	3.85e-05	0.000311	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PDYN—epilepsy syndrome	3.85e-05	0.000311	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCR7—epilepsy syndrome	3.85e-05	0.000311	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CHRM1—epilepsy syndrome	3.85e-05	0.000311	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CCR5—epilepsy syndrome	3.79e-05	0.000306	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR7—epilepsy syndrome	3.78e-05	0.000305	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCR3—epilepsy syndrome	3.71e-05	0.0003	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—HTR2A—epilepsy syndrome	3.71e-05	0.000299	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HBEGF—epilepsy syndrome	3.67e-05	0.000296	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CDC42—epilepsy syndrome	3.62e-05	0.000292	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GAL—epilepsy syndrome	3.62e-05	0.000292	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GFAP—epilepsy syndrome	3.62e-05	0.000292	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ATP2A2—epilepsy syndrome	3.62e-05	0.000292	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NPY—epilepsy syndrome	3.62e-05	0.000292	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AKT3—epilepsy syndrome	3.61e-05	0.000291	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CHRM3—epilepsy syndrome	3.58e-05	0.000289	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CASP2—epilepsy syndrome	3.58e-05	0.000289	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GRM5—epilepsy syndrome	3.58e-05	0.000289	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AGT—epilepsy syndrome	3.52e-05	0.000284	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AVP—epilepsy syndrome	3.51e-05	0.000283	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HSPB1—epilepsy syndrome	3.49e-05	0.000282	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—OXT—epilepsy syndrome	3.49e-05	0.000282	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CRH—epilepsy syndrome	3.49e-05	0.000282	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CXCL2—epilepsy syndrome	3.49e-05	0.000282	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCL3—epilepsy syndrome	3.49e-05	0.000282	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ABCG2—epilepsy syndrome	3.49e-05	0.000282	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CCR5—epilepsy syndrome	3.45e-05	0.000278	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CX3CR1—epilepsy syndrome	3.43e-05	0.000277	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP2C19—epilepsy syndrome	3.4e-05	0.000274	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP11A1—epilepsy syndrome	3.38e-05	0.000273	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—HTR2A—epilepsy syndrome	3.37e-05	0.000272	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CHRM2—epilepsy syndrome	3.37e-05	0.000272	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—BDKRB1—epilepsy syndrome	3.37e-05	0.000272	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CX3CL1—epilepsy syndrome	3.37e-05	0.000272	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—ALB—epilepsy syndrome	3.36e-05	0.000271	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CDC42—epilepsy syndrome	3.29e-05	0.000265	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GABBR1—epilepsy syndrome	3.28e-05	0.000264	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.26e-05	0.000263	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TSC1—epilepsy syndrome	3.25e-05	0.000262	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PTK2B—epilepsy syndrome	3.25e-05	0.000262	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AGT—epilepsy syndrome	3.2e-05	0.000258	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AVP—epilepsy syndrome	3.18e-05	0.000257	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCR2—epilepsy syndrome	3.16e-05	0.000255	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SST—epilepsy syndrome	3.16e-05	0.000255	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NTRK2—epilepsy syndrome	3.16e-05	0.000255	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HRH3—epilepsy syndrome	3.14e-05	0.000253	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—DUSP6—epilepsy syndrome	3.13e-05	0.000253	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—OPRM1—epilepsy syndrome	3.09e-05	0.000249	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADRA2A—epilepsy syndrome	3.09e-05	0.000249	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PLAT—epilepsy syndrome	3.08e-05	0.000248	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CYP2D6—epilepsy syndrome	3.05e-05	0.000246	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CCR5—epilepsy syndrome	2.98e-05	0.000241	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—BDKRB2—epilepsy syndrome	2.97e-05	0.00024	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CXCL12—epilepsy syndrome	2.97e-05	0.00024	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—POMC—epilepsy syndrome	2.97e-05	0.000239	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.96e-05	0.000238	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.94e-05	0.000237	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCR3—epilepsy syndrome	2.92e-05	0.000235	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.92e-05	0.000235	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—JUNB—epilepsy syndrome	2.91e-05	0.000235	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CNR1—epilepsy syndrome	2.91e-05	0.000235	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PLCB1—epilepsy syndrome	2.9e-05	0.000234	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—BCHE—epilepsy syndrome	2.89e-05	0.000233	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	2.87e-05	0.000231	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NPY—epilepsy syndrome	2.85e-05	0.000229	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ATP2A2—epilepsy syndrome	2.85e-05	0.000229	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HTR7—epilepsy syndrome	2.84e-05	0.000229	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AGT—epilepsy syndrome	2.77e-05	0.000223	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HBEGF—epilepsy syndrome	2.76e-05	0.000223	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—SLC2A1—epilepsy syndrome	2.76e-05	0.000223	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HSPB1—epilepsy syndrome	2.74e-05	0.000221	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCL2—epilepsy syndrome	2.74e-05	0.000221	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CRH—epilepsy syndrome	2.74e-05	0.000221	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—OXT—epilepsy syndrome	2.74e-05	0.000221	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCL3—epilepsy syndrome	2.74e-05	0.000221	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PLCB1—epilepsy syndrome	2.73e-05	0.00022	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—TH—epilepsy syndrome	2.72e-05	0.000219	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKT3—epilepsy syndrome	2.71e-05	0.000219	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCR5—epilepsy syndrome	2.71e-05	0.000218	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—POMC—epilepsy syndrome	2.69e-05	0.000217	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—HTR2A—epilepsy syndrome	2.65e-05	0.000214	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADAM10—epilepsy syndrome	2.65e-05	0.000213	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CCL2—epilepsy syndrome	2.63e-05	0.000213	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.56e-05	0.000206	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PTK2B—epilepsy syndrome	2.55e-05	0.000206	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TSC1—epilepsy syndrome	2.55e-05	0.000206	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AGT—epilepsy syndrome	2.51e-05	0.000203	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	2.5e-05	0.000202	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SST—epilepsy syndrome	2.48e-05	0.0002	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCR2—epilepsy syndrome	2.48e-05	0.0002	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NTRK2—epilepsy syndrome	2.48e-05	0.0002	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	2.48e-05	0.0002	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	2.47e-05	0.000199	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—DUSP6—epilepsy syndrome	2.46e-05	0.000198	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PLAT—epilepsy syndrome	2.42e-05	0.000195	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	2.39e-05	0.000193	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—SRC—epilepsy syndrome	2.38e-05	0.000192	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCL12—epilepsy syndrome	2.33e-05	0.000188	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	2.33e-05	0.000188	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—POMC—epilepsy syndrome	2.33e-05	0.000188	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.32e-05	0.000187	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—VEGFA—epilepsy syndrome	2.32e-05	0.000187	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.31e-05	0.000187	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—JUNB—epilepsy syndrome	2.29e-05	0.000185	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CNR1—epilepsy syndrome	2.29e-05	0.000185	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	2.28e-05	0.000184	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	2.27e-05	0.000183	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	2.26e-05	0.000183	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CAT—epilepsy syndrome	2.24e-05	0.000181	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	2.24e-05	0.00018	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	2.2e-05	0.000178	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	2.19e-05	0.000177	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	2.19e-05	0.000177	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	2.18e-05	0.000176	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	2.17e-05	0.000175	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	2.13e-05	0.000172	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	2.12e-05	0.000171	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.12e-05	0.000171	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	2.09e-05	0.000169	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	2.08e-05	0.000168	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	2.07e-05	0.000167	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	2.04e-05	0.000164	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GPX1—epilepsy syndrome	2.03e-05	0.000163	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.99e-05	0.000161	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	1.97e-05	0.000159	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	1.95e-05	0.000157	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	1.94e-05	0.000157	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	1.89e-05	0.000153	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	1.89e-05	0.000152	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	1.88e-05	0.000152	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	1.85e-05	0.000149	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	1.81e-05	0.000146	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	1.78e-05	0.000143	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AGT—epilepsy syndrome	1.78e-05	0.000143	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.75e-05	0.000141	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—APOE—epilepsy syndrome	1.74e-05	0.00014	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.74e-05	0.00014	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	1.73e-05	0.00014	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.72e-05	0.000139	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.72e-05	0.000139	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.66e-05	0.000134	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	1.64e-05	0.000133	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	1.6e-05	0.000129	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1.59e-05	0.000128	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	1.57e-05	0.000126	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.56e-05	0.000126	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.5e-05	0.000121	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.49e-05	0.00012	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.49e-05	0.00012	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.48e-05	0.000119	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1.46e-05	0.000117	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	1.43e-05	0.000115	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.41e-05	0.000113	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.37e-05	0.000111	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.37e-05	0.00011	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ALB—epilepsy syndrome	1.36e-05	0.00011	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.31e-05	0.000105	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.28e-05	0.000103	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	1.25e-05	0.000101	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	1.22e-05	9.87e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	1.19e-05	9.62e-05	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.19e-05	9.59e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.18e-05	9.5e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	1.14e-05	9.23e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.11e-05	8.98e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	1.11e-05	8.92e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.08e-05	8.71e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	1.03e-05	8.28e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	1.03e-05	8.28e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	1.01e-05	8.12e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	9.99e-06	8.06e-05	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	9.34e-06	7.54e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	9.26e-06	7.47e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	8.99e-06	7.25e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	8.75e-06	7.06e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	8.48e-06	6.84e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	8.06e-06	6.51e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	7.85e-06	6.34e-05	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	6.38e-06	5.14e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	5.99e-06	4.83e-05	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	5.01e-06	4.04e-05	CbGpPWpGaD
